"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
As the clock ticks closer to the new year, investors can’t help but marvel at the impressive performance of Wall Street in 2023. The Dow Jones Industrial Average (DJINDICES: ^DJI) hit a historic high, with the benchmark S&P 500 (SNPINDEX: ^GSPC) and innovation-driven Nasdaq Composite …
Investing in companies capable of advancing and profiting from influential trends can be a life-changing path to wealth creation. Not every stock you buy will go on to be a world-beating success story, but holding just a few big winners over the long term can …
While isolationism and nationalism appear to be rising themes in global politics, with the investing game, diversity is a core strength, thus boosting the narrative of international stocks. Fundamentally, going abroad for profits may provide risk management. Just like you wouldn’t put all your money …
The stock market in 2023 witnessed an electrifying surge led by the “Magnificent Seven,” comprising technology giants like Tesla, Nvidia, Apple, Amazon, Meta Platforms, Microsoft, and Alphabet. The collectively awe-inspiring rise of these companies, ranging from 50% to 250%, played a pivotal role in propelling …
Emerson Electric's recent acquisition of National Instruments has reverberated throughout the business world, causing a ripple effect that has captured the attention of industry experts and investors alike. With the deal valued at an impressive $8.2 billion and receiving approval from both China and the …
Conns, the home goods retailer operating through credit and retail segments, has experienced a significant downturn in its financial performance during the third quarter of FY23. With a decline in sales across all departments, the company reported a 20.7% decrease in revenues, amounting to $321.2 …
Farmer Brothers, a prominent coffee manufacturer and distributor, recently announced its financial results for the third quarter, which fell short of expectations. The company's GAAP EPS came in at -$0.57, missing expectations by $0.17, and its revenue of $124.2 million also fell short by $9.8 …
As an investor, I've come across an intriguing statistic that has piqued my curiosity. CytoDyn, a biotech company specializing in innovative therapies, is currently facing a federal indictment. With their former CEO under scrutiny for issuing false statements and misleading documents, the company has found …
The recent initial public offering (IPO) of Monogram Orthopedics has resulted in a significant surge in the company's stock prices. Monogram Orthopedics' shares experienced a remarkable increase of up to 317%, with the stock opening at $38 and reaching an early high of $48.99. Despite …
NIO, a prominent player in the electric vehicle industry, has recently announced a substantial strategic equity investment of 2.2 billion dollars from CYVN. This sizable financial boost is expected to have a significant impact on NIO's expansion plans and operational capabilities. At a time when …